financetom
Business
financetom
/
Business
/
Santander Asset Management Expands FX Derivatives to Eurex
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Santander Asset Management Expands FX Derivatives to Eurex
May 23, 2024 3:42 AM

06:11 AM EDT, 05/23/2024 (MT Newswires) -- Santander Asset Management has started trading its FX derivatives business at Eurex with plans to add FX options business as well, the German derivatives exchange said on Wednesday.

Banco Santander is acting as clearing member and Deutsche Bank serves as liquidity provider, according to a Eurex statement.

Santander and Deutsche Bank have also traded the first FX options block trade ever at Eurex.

More market participants are using FX derivatives as "a tool to hedge their portfolio performance," using the instruments to mitigate counterparty credit risk, navigate uncleared margin rules and optimize capital costs through centrally cleared FX futures and options. Eurex said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Trane Technologies Keeps Quarterly Dividend at $0.94 a Share; Payable June 30 to Holders of Record as of June 6
--Trane Technologies Keeps Quarterly Dividend at $0.94 a Share; Payable June 30 to Holders of Record as of June 6
Apr 3, 2025
09:59 AM EDT, 04/03/2025 (MT Newswires) -- Price: 334.39, Change: -13.55, Percent Change: -3.89 ...
Akebia Therapeutics Says EMA Panel Recommends Approval of Xoanacyl for Chronic Kidney Disease Treatment
Akebia Therapeutics Says EMA Panel Recommends Approval of Xoanacyl for Chronic Kidney Disease Treatment
Apr 3, 2025
10:01 AM EDT, 04/03/2025 (MT Newswires) -- Akebia Therapeutics ( AKBA ) said Thursday that the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Xoanacyl for treating elevated serum phosphorus and iron deficiency in adults with chronic kidney disease. The company said Averoa, a biopharmaceutical company specializing in renal treatments, licensed the rights from Akebia...
Covalon Technologies up 2.7%, Reports No Tariff Impact on Products
Covalon Technologies up 2.7%, Reports No Tariff Impact on Products
Apr 3, 2025
09:59 AM EDT, 04/03/2025 (MT Newswires) -- Covalon Technologies ( CVALF ) up 2.7% on last look, on Thursday confirmed that its wound care products will not be impacted by the April 2 tariff announcements by U.S. President Donald Trump. Under the United States-Mexico-Canada Agreement (USMCA), certain products are not subject to the recent tariffs. Covalon's ( CVALF ) products,...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved